全球胃肠道扩张给药系统市场

预计到 2030 年，全球胃肠扩张药物输送系统市场规模将达到 199 亿美元

全球胃肠道可扩展药物输送系统市场规模预计在2024年为151亿美元，预计到2030年将达到199亿美元，2024年至2030年期间的复合年增长率为4.6%。漂浮药物输送系统是本报告分析的细分市场之一，预计其复合年增长率为3.4%，到分析期结束时规模将达到67亿美元。可扩展药物输送系统细分市场在分析期间的复合年增长率预计为6.2%。

美国市场规模估计为 41 亿美元，中国市场预期复合年增长率为 7.1%

美国胃肠扩张式给药系统市场规模预计2024年达到41亿美元。作为世界第二大经济体，中国市场规模预计到2030年将达到38亿美元，在2024-2030年的分析期间内，复合年增长率为7.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为2.3%和4.6%。在欧洲，预计德国市场的复合年增长率为2.9%。

全球肠道扩张药物输送系统市场—主要趋势与驱动因素摘要

为什么胃肠扩张药物传递系统会彻底改变口服药物治疗？

肠道扩张给药系统 (GRDDS) 能够延长药物在胃中的停留时间，从而提高吸收率和生物有效性度，彻底改变了口服给药方式。此系统尤其适用于上消化道吸收窗口较窄或在碱性条件下易降解的药物。透过延长药物在胃中的停留时间，GRDDS 可以提高药物的疗效，同时减少给药频率，从而提高患者的依从性。

胃滞留技术（例如漂浮式、生物黏附式、可膨胀式和可扩张式药物递送系统）的发展，为製药公司提供了优化药物性能的创新解决方案。漂浮式药物传递系统 (FDDS) 是最广泛使用的系统之一，它利用低密度製剂在胃液中保持漂浮状态，确保药物持续释放。同样，生物黏附系统黏附于胃黏膜，延长药物与吸收部位的接触时间。随着製药公司专注于提高药物溶解度和控制释放机制，胃滞留系统 (GRDDS) 正成为现代口服药物製剂中不可或缺的一部分。

哪个治疗领域正在推动胃肠道扩张药物输送系统的需求？

胃肠道可扩展药物传递系统广泛应用于多个治疗领域，包括胃肠道疾病、糖尿病、心血管疾病和感染疾病。质子帮浦质子帮浦阻断剂(PPI) 和 H2 受体拮抗剂常用于治疗胃食道逆流症 (GERD) 和消化性溃疡，它们需要长时间在胃内滞留才能达到最佳疗效，因此 GRDDS 对其疗效显着。同样，用于幽门螺旋桿菌根除治疗的抗生素，例如阿莫西林和甲硝唑，也采用胃滞留剂型来提高根除率。

在糖尿病管理领域，GRDDS 正在提高Metformin等药物的生物有效性，这些药物在上消化道的吸收窗口有限。他汀类药物和β受体阻断剂心血管药物也越来越多地采用胃滞留技术配製，以控制药物释放并提高患者的依从性。在疼痛管理和中枢神经系统 (CNS) 药物领域，对 GRDDS 的需求正在进一步扩大，因为在这些领域，持续药物释放可以最大限度地减少副作用并改善治疗效果。

哪些技术进步可以增强胃滞留药物传递？

聚合物科学和奈米技术的进步显着提高了胃肠道可扩展药物传输系统的功效。基于智慧聚合物的製剂已被开发出来，透过控制胃内的肿胀、膨胀和黏附来优化药物释放速率。此外，奈米製剂可增强难溶性药物的溶解度和吸收率，从而实现更高效的药物传递。

另一项重大技术创新是将微电子监测技术融入胃滞留系统 (GRDDS)，从而能够即时追踪药物释放和胃内滞留。内建感测器的智慧型锭剂可以为医生提供药物吸收模式数据，并改善个人化治疗方法。 3D列印技术也正在被研究用于开发客製化的胃滞留药物配方，从而能够精确控制药物释放曲线。这些技术进步正在使GRDDS更有效率、更具适应性、患者使用体验更佳。

哪些因素推动了胃肠道扩张药物输送系统市场的成长？

胃肠道可扩展药物传输系统市场的成长受到多种因素的推动，例如胃肠道疾病盛行率的增加、对控制释放製剂的需求不断增长、基于聚合物的输送技术的进步等。老年人口的成长需要长期服用具有更高生物有效性的药物，这也促进了市场扩张。

製药业日益重视以患者为中心的製剂，促使其对胃肠道延缓给药系统 (GRDDS) 研发的投资不断增加。此外，核准预计将持续成长，从而塑造口服药物治疗的未来。

部分

类型（漂浮给药系统、可扩展给药系统、生物黏附给药系统、高密度系统、其他胃肠道可扩展给药系统）、剂量（锭剂剂量、胶囊剂量、凝胶剂量、液体剂量、其他剂量）、分销渠道（医院药房分销渠道、零售药房分销渠道、网上药房分销渠道）

受访公司范例

• AbbVie Inc.
• Alcon Inc.
• AptarGroup, Inc.
• Ashland Global Holdings Inc.
• AstraZeneca plc
• Cadila Pharmaceuticals
• Catalent, Inc.
• Colorcon, Inc.
• Evonik Industries AG
• Evotec SE
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc
• Lonza Group AG
• Lupin Limited
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi SA
• Sun Pharmaceutical Industries Ltd.
• Torrent Pharmaceuticals Ltd.

人工智慧集成

我们正在利用检验的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Gastroretentive Drug Delivery Systems Market to Reach US$19.9 Billion by 2030

The global market for Gastroretentive Drug Delivery Systems estimated at US$15.1 Billion in the year 2024, is expected to reach US$19.9 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2024-2030. Floating Drug Delivery System, one of the segments analyzed in the report, is expected to record a 3.4% CAGR and reach US$6.7 Billion by the end of the analysis period. Growth in the Expandable Drug Delivery System segment is estimated at 6.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.1 Billion While China is Forecast to Grow at 7.1% CAGR

The Gastroretentive Drug Delivery Systems market in the U.S. is estimated at US$4.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.8 Billion by the year 2030 trailing a CAGR of 7.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.3% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.9% CAGR.

Global Gastroretentive Drug Delivery Systems Market - Key Trends & Drivers Summarized

Why Are Gastroretentive Drug Delivery Systems Transforming Oral Drug Therapies?

Gastroretentive drug delivery systems (GRDDS) have revolutionized oral drug administration by enabling prolonged retention of drugs in the stomach, improving absorption and bioavailability. These systems are particularly beneficial for drugs with a narrow absorption window in the upper gastrointestinal tract or those that degrade in alkaline conditions. By ensuring extended gastric residence time, GRDDS enhance the therapeutic efficacy of drugs while reducing dosing frequency, leading to improved patient compliance.

The development of gastroretentive technologies, such as floating, bioadhesive, swelling, and expandable drug delivery systems, has provided pharmaceutical companies with innovative solutions to optimize drug performance. Floating drug delivery systems (FDDS) are among the most widely used, utilizing low-density formulations that remain buoyant in gastric fluids, ensuring sustained drug release. Similarly, bioadhesive systems adhere to the gastric mucosa, prolonging drug contact time with absorption sites. As pharmaceutical companies focus on improving drug solubility and controlled release mechanisms, GRDDS are becoming an integral part of modern oral drug formulations.

Which Therapeutic Areas Are Driving Demand for Gastroretentive Drug Delivery Systems?

Gastroretentive drug delivery systems are widely used across multiple therapeutic areas, including gastrointestinal disorders, diabetes, cardiovascular diseases, and infectious diseases. Proton pump inhibitors (PPIs) and H2-receptor antagonists, commonly used for GERD and peptic ulcer treatment, benefit significantly from GRDDS, as they require prolonged gastric retention for optimal effectiveness. Similarly, antibiotics such as amoxicillin and metronidazole used in Helicobacter pylori eradication therapy leverage gastroretentive formulations to enhance bacterial eradication rates.

In the diabetes management sector, GRDDS are improving the bioavailability of drugs such as metformin, which has a limited absorption window in the upper GI tract. Cardiovascular drugs, including statins and beta-blockers, are also being formulated with gastroretentive technologies to improve controlled drug release and patient adherence. The demand for GRDDS is further expanding in the pain management and central nervous system (CNS) drug sectors, where sustained drug release can minimize side effects and improve therapeutic outcomes.

What Technological Innovations Are Enhancing Gastroretentive Drug Delivery?

Advancements in polymer science and nanotechnology have significantly improved the effectiveness of gastroretentive drug delivery systems. Smart polymer-based formulations are being developed to achieve controlled swelling, expansion, and adherence within the stomach, optimizing drug release kinetics. Additionally, nano-formulations are enhancing the solubility and absorption of poorly water-soluble drugs, ensuring more efficient drug delivery.

Another major innovation is the incorporation of microelectronic monitoring in GRDDS, allowing real-time tracking of drug release and gastric retention. Smart pills with embedded sensors can provide physicians with data on drug absorption patterns, improving personalized treatment approaches. 3D printing technology is also being explored to develop customized gastroretentive drug formulations, enabling precise control over drug release profiles. These technological advancements are making GRDDS more effective, adaptable, and patient-friendly.

What Factors Are Fueling the Growth of the Gastroretentive Drug Delivery Systems Market?

The growth in the gastroretentive drug delivery systems market is driven by several factors, including the increasing prevalence of gastrointestinal diseases, rising demand for controlled-release drug formulations, and advancements in polymer-based delivery technologies. The growing geriatric population, which requires long-term medication with improved bioavailability, has also contributed to market expansion.

The pharmaceutical industry’s focus on patient-centric drug formulations has led to increased investment in GRDDS research and development. Additionally, regulatory approvals for gastroretentive formulations are driving their commercialization, particularly in the treatment of chronic diseases such as diabetes and cardiovascular disorders. The expansion of biopharmaceutical research and the adoption of innovative drug delivery mechanisms are further propelling market growth. As pharmaceutical companies continue to explore novel drug formulations, the demand for gastroretentive drug delivery systems is expected to grow, shaping the future of oral drug therapies.

SCOPE OF STUDY:

The report analyzes the Gastroretentive Drug Delivery Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems, Other Gastroretentive Drug Delivery Systems); Dosage (Tablets Dosage, Capsule Dosage, Gel Dosage, Liquid Dosage, Other Dosages); Distribution Channel (Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel, Online Pharmacies Distribution Channel)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

• AbbVie Inc.
• Alcon Inc.
• AptarGroup, Inc.
• Ashland Global Holdings Inc.
• AstraZeneca plc
• Cadila Pharmaceuticals
• Catalent, Inc.
• Colorcon, Inc.
• Evonik Industries AG
• Evotec SE
• F. Hoffmann-La Roche AG
• GlaxoSmithKline plc
• Lonza Group AG
• Lupin Limited
• Merck & Co., Inc.
• Novartis AG
• Pfizer Inc.
• Sanofi S.A.
• Sun Pharmaceutical Industries Ltd.
• Torrent Pharmaceuticals Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Gastroretentive Drug Delivery Systems - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Need for Enhanced Oral Bioavailability of Low-Solubility Drugs Drives Adoption of Gastroretentive Delivery Systems
  • Increased Focus on Site-Specific Drug Release Enhances the Business Case for Gastroretentive Platforms
  • Growing Prevalence of Gastric Disorders and Chronic Conditions Spurs Demand for Targeted Gastric Drug Delivery
  • Technological Advancements in Floating, Mucoadhesive, and Expandable Systems Improve Gastric Retention Efficiency
  • Expansion of Controlled and Sustained Release Drug Markets Strengthens Use of Gastroretentive Formulations
  • OEM Innovation in Polymer-Based Carriers and Swellable Systems Enhances Formulation Stability
  • Shift Toward Patient-Centric Oral Therapies Supports Development of Gastroretentive Drug Systems
  • Rising Demand for Once-Daily Dosing and Reduced Side Effects Drives Innovation in Gastric Retention Mechanisms
  • Emergence of Gastroretentive Systems as Lifecycle Extension Tools for Off-Patent Drugs Creates Growth Opportunities
  • Integration of Predictive Modeling and Simulation Tools Improves GRDDS Design and Development Timelines
  • Growing Research in Helicobacter pylori Eradication and Localized GI Therapies Increases Application Scope
  • Increasing FDA Approvals of GRDDS-Based Formulations Validates Clinical Efficacy and Commercial Viability
  • Demand for Oral Delivery of Peptides and Macromolecules Spurs Interest in Advanced Gastric Retentive Technologies
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Gastroretentive Drug Delivery Systems Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Gastroretentive Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Gastroretentive Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Floating Drug Delivery System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Floating Drug Delivery System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Floating Drug Delivery System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Expandable Drug Delivery System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Expandable Drug Delivery System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Expandable Drug Delivery System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Bioadhesive Drug Delivery System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Bioadhesive Drug Delivery System by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Bioadhesive Drug Delivery System by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for High Density Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for High Density Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for High Density Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Gastroretentive Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Gastroretentive Drug Delivery Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Other Gastroretentive Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Dosages by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Dosages by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Other Dosages by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Tablets Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Tablets Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Tablets Dosage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Capsule Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Capsule Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Capsule Dosage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Gel Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Gel Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Gel Dosage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Liquid Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Liquid Dosage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Liquid Dosage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Hospital Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Hospital Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Retail Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Retail Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Online Pharmacies Distribution Channel by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for Online Pharmacies Distribution Channel by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• JAPAN
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• CHINA
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• EUROPE
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Gastroretentive Drug Delivery Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• FRANCE
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 92: France Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• GERMANY
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 119: UK Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• INDIA
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 176: India Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Gastroretentive Drug Delivery Systems by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Gastroretentive Drug Delivery Systems by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030
• AFRICA
  • Gastroretentive Drug Delivery Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Gastroretentive Drug Delivery Systems by Type - Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Gastroretentive Drug Delivery Systems by Type - Percentage Breakdown of Value Sales for Floating Drug Delivery System, Expandable Drug Delivery System, Bioadhesive Drug Delivery System, High Density Systems and Other Gastroretentive Drug Delivery Systems for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Gastroretentive Drug Delivery Systems by Dosage - Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Gastroretentive Drug Delivery Systems by Dosage - Percentage Breakdown of Value Sales for Other Dosages, Tablets Dosage, Capsule Dosage, Gel Dosage and Liquid Dosage for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Gastroretentive Drug Delivery Systems by Distribution Channel - Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Gastroretentive Drug Delivery Systems by Distribution Channel - Percentage Breakdown of Value Sales for Hospital Pharmacies Distribution Channel, Retail Pharmacies Distribution Channel and Online Pharmacies Distribution Channel for the Years 2015, 2025 & 2030

IV. COMPETITION